Able Biolabs
PrivateLast Round
Accelerator
Apr 1, 2024
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Able Biolabs is a drug discovery company that provides preclinical and clinical R&D services for clients in the biotech and consumer goods industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Able Biolabs Comparables
Compare Able Biolabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioModels, LLC | 80% | |
| Reaction Biology Corporation | 72% | |
| Charles River Laboratories | 67% | |
Able Biolabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2024 |
Able Biolabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biostack Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 55% MoM, reaching 1K.
- May 21, 2026
Monthly visitors grew 688% MoM, reaching 5K.
Able Biolabs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Able Biolabs's valuation, stock price, and market status.